mycobacterium
tuberculosi
member
bacteri
mycobacteriacea
famili
known
caus
tuberculosi
tb
human
world
health
organ
report
death
million
tuberculosisinfect
person
estim
million
new
case
tuberculosi
patient
per
year
worldwid
emerg
multidrugresist
strain
make
situat
omin
therefor
develop
altern
treatment
drugsuscept
multidrugresist
strain
discoveri
novel
highli
conserv
drug
target
warrant
gquadruplexform
nucleic
acid
motif
one
studi
evolutionarili
conserv
drug
target
copious
found
critic
region
genom
variou
organ
rang
eukaryot
prokaryot
virus
human
gquadruplex
found
associ
regul
vital
cellular
process
replic
recombin
transcript
translat
addit
telomer
gquadruplex
also
identifi
promot
region
variou
protooncogen
kra
ckit
pdgfa
cmyc
vegf
cmyb
consid
potenti
therapeut
target
cancer
treatment
recent
variou
virus
hiv
ebola
viru
hepat
b
viru
hbv
herp
simplex
viru
hsv
human
papillomaviru
hpv
hepat
c
viru
hcv
sever
acut
respiratori
syndrom
sar
coronaviru
zika
viru
epsteinbarr
viru
ebv
also
report
harbor
conserv
gquadruplex
structur
code
region
variou
structur
nonstructur
protein
case
gquadruplex
either
play
regulatori
role
replic
transcript
packag
viral
genom
help
virus
immun
evas
among
vast
kingdom
prokaryot
pathogen
bacteria
explor
presenc
gquadruplex
sequenc
genom
neisseria
gonorrhoea
deinococcu
radioduran
conserv
gquadruplex
shown
respons
antigen
variat
neisseria
gonorrhoea
treponema
pallidium
previous
sever
strainspecif
gquadruplex
also
report
genom
mycobacterium
tuberculosi
strain
therefor
present
studi
sought
explor
novel
highli
conserv
put
gquadruplexform
sequenc
avail
complet
sequenc
strain
tuberculosi
bioinformat
analysi
reveal
presenc
highli
conserv
potenti
gquadruplex
motif
pgq
three
essenti
gene
tuberculosi
name
espk
espb
respons
virul
bacteria
insid
host
cell
insight
pathogen
mechan
tuberculosi
infect
indic
facult
intracellular
human
pathogen
surviv
host
environ
prevent
matur
phagosom
phagolysosom
previous
tuberculosi
genom
reveal
possess
extend
region
differ
locu
harbor
gene
earli
secretori
antigen
target
system
secret
machineri
type
vii
secret
system
util
espk
encod
secret
cultur
filtrat
protein
dimer
figur
secret
dimer
complex
enter
endoplasm
reticulum
er
macrophag
sequest
protein
essenti
compon
mhc
class
system
sequestr
reduc
mhc
class
imedi
antigen
present
innat
immun
respons
host
cell
addit
also
secret
anoth
esxsubstr
protein
espb
espb
interact
ctermin
region
espk
protein
directli
portray
inhibitori
role
matur
phagosom
upon
espkassist
secret
espb
outsid
cytosol
secret
machineri
figur
espb
undergo
oligomer
bind
phospholipid
host
macrophag
initi
membranolyt
poreform
phenomenon
insid
phagosom
serv
crucial
initi
step
immun
evas
bacteria
thu
secret
espb
help
bacteria
suppress
innat
immun
respons
host
cell
promot
surviv
within
host
figur
insight
secret
machineri
reveal
crucial
role
espb
espk
protein
pathogenesi
tuberculosi
within
host
suggest
inhibit
espk
espb
express
could
lead
synergist
reduct
tuberculosi
virul
pathogenesi
thu
repres
novel
therapeut
approach
gene
anoth
pgqpossess
gene
previous
report
involv
sterol
biosynthesi
pathway
membran
format
bioinformat
analysi
reveal
pgq
espk
espb
gene
present
work
sought
investig
regulatori
role
pgq
express
pgqpossess
gene
accomplish
use
variou
biophys
biochem
techniqu
confirm
format
gquadruplex
structur
predict
pgq
isotherm
titrat
calorimetri
itc
circular
dichroism
cd
melt
analysi
allow
us
demonstr
affin
pgq
next
polymeras
stop
assay
qrtpcr
assay
rna
tuberculosi
cultur
treat
confirm
downregul
pgq
possess
gene
espk
espb
therefor
studi
demonstr
novel
approach
develop
activ
therapeut
tuberculosi
infect
exploit
pgq
target
figur
current
effect
drug
avail
treatment
tuberculosi
infect
emerg
extrem
drugresist
strain
latent
infect
ring
global
alarm
investig
novel
conserv
drug
target
drug
regimen
depend
nucleotid
base
composit
nucleic
acid
adopt
sever
distinct
secondari
structur
duplex
triplex
hairpin
quadruplex
structur
among
secondari
structur
gquadruplex
structur
repres
studi
evolutionarili
conserv
drug
target
sever
small
molecul
develop
modul
stabil
destabil
gquadruplex
structur
potenti
use
promis
drug
target
battl
human
pathogen
consid
suitabl
gquadruplex
evolutionarili
conserv
promis
drug
target
search
genom
sequenc
avail
strain
tuberculosi
ncbi
databas
presenc
ptq
mtbpgq
employ
gquadruplex
predict
algorithm
previous
develop
group
predict
confirm
tool
develop
group
tabl
structur
fold
reli
differ
pattern
length
consecut
gtract
loop
figur
set
constraint
nt
minimum
length
gtract
nt
least
highest
length
loop
respect
predict
algorithm
set
paramet
employ
complet
sequenc
tuberculosi
strain
tabl
allow
us
identifi
potenti
sequenc
tabl
consid
like
two
sequenc
may
associ
similar
function
sought
correl
sequenc
similar
mtbpgq
function
unweight
pair
group
method
arithmet
mean
upgma
cluster
method
util
measur
similar
larg
set
mtbpgq
defin
like
hierarchi
given
set
string
cluster
analysi
cluster
pgq
almost
ident
sequenc
similar
function
suscept
form
topolog
tabl
combat
multidrugresist
bacteri
infect
evolutionari
conserv
requisit
satisfi
one
criteria
work
promis
drug
target
therefor
employ
blast
algorithm
calcul
occurr
cluster
avail
strain
tuberculosi
demonstr
conserv
cluster
employ
follow
equat
p
n
n
p
frequenc
occurr
n
total
number
strain
particular
pgq
present
n
total
number
tuberculosi
strain
tabl
demonstr
detail
mtbpgq
occur
frequenc
present
essenti
gene
strain
tuberculosi
analysi
chosen
conserv
mtbpgq
presenc
genom
drugsuscept
drugresist
strain
bacteria
cluster
analysi
follow
conserv
map
reveal
three
mtbpgq
conserv
tabl
present
three
essenti
gene
bacteria
name
espk
espb
figur
display
consensu
sequenc
conserv
mtbpgq
obtain
r
programmingbas
deciph
packag
figur
provid
schemat
locat
gene
id
locu
tag
genom
strand
direct
pgqpossess
gene
phylogenet
tree
obtain
neighborjoin
method
depict
conserv
mtbpgq
among
member
mycobacteria
famili
includ
mycobacterium
bovi
mycobacterium
canettii
mycobacterium
microti
mycobacterium
haemophilum
figur
circular
dichroism
among
depend
method
portray
format
structur
dna
oligonucleotid
previou
studi
observ
posit
peak
nm
neg
peak
nm
correspond
parallel
wherea
posit
peak
nm
neg
peak
nm
indic
antiparallel
format
two
posit
peak
nm
coupl
neg
peak
nm
repres
mix
hybrid
structur
differ
cation
exert
variabl
effect
stabil
fold
pattern
structur
rank
stabil
abil
among
wellstudi
cation
follow
k
na
mg
li
therefor
assess
topolog
conserv
mtbpgq
use
cd
spectra
cd
melt
curv
analysi
four
differ
buffer
contain
relat
cation
k
na
mg
li
cd
spectra
analysi
reveal
predominantli
parallel
topolog
exhibit
conserv
mtbpgq
expect
molar
ellipt
melt
temperatur
mtbpgq
found
higher
presenc
k
ion
figur
cd
spectra
analysi
perform
presenc
increas
concentr
k
ion
reveal
increas
molar
ellipt
function
k
ion
concentr
figur
mutat
central
guanin
nucleotid
g
stretch
thymin
evalu
abil
mutat
mtbpgq
mutmtbpgq
k
buffer
tabl
mutant
show
cd
signal
correspond
topolog
suggest
disrupt
structur
format
guanin
mutat
figur
perform
electrophoret
gel
mobil
shift
assay
emsa
check
presenc
multimer
structur
determin
molecular
assembl
solut
case
fold
fastmov
oligonucleotid
band
consid
correspond
intramolecular
topolog
wherea
slowmov
oligonucleotid
band
like
correspond
intermolecular
structur
examin
rate
migrat
mtbpgq
oligo
well
mutant
sequenc
nativ
page
mtbpgq
oligonucleotid
migrat
faster
rate
compar
mutant
sequenc
suggest
format
intramolecular
complex
pgq
figur
nmr
spectroscopi
highli
reliabl
techniqu
confirm
format
stabl
structur
nucleic
acid
therefor
examin
onedimension
proton
nmr
h
nmr
spectra
mtbpgq
vitro
h
nmr
chemic
shift
signal
appear
ppm
pertain
hoogsteen
base
pair
involv
format
wherea
signal
ppm
pertain
watsoncrick
base
pair
encouragingli
h
nmr
spectra
exhibit
imino
proton
reson
ppm
confirm
format
mtbpgq
figur
variou
bind
ligand
investig
therapeut
potenti
affect
stabil
structur
etc
act
anticanc
agent
stabil
structur
present
human
telomer
also
inhibit
viral
rna
process
insid
host
cell
stabil
structur
present
l
gene
ebola
viru
act
antiebola
viru
ebov
agent
recent
shown
inhibit
tuberculosi
growth
cellular
target
remain
identifi
studi
assess
stabil
activ
mtbpgq
cd
melt
curv
analysi
melt
curv
mtbpgq
absenc
presenc
yield
increas
melt
temperatur
c
indic
stabil
effect
thermost
structur
form
mtbpgq
figur
assess
bind
affin
form
mtbpgq
oligo
itc
chang
enthalpi
dh
associ
bind
neg
indic
energet
favor
bind
mtbpgq
associ
constant
k
highaffin
site
respect
result
confirm
thermodynam
stabl
interact
mtbpgq
affin
micromolar
rang
figur
also
took
sequenc
neg
control
observ
select
structur
itc
result
indic
tighter
bind
respect
nonquadruplexform
sequenc
figur
observ
ic
valu
mm
valu
lower
ic
valu
malign
normal
eukaryot
cell
stall
replic
machineri
site
next
sought
investig
whether
bind
pgq
motif
inhibit
dna
replic
accomplish
employ
two
variant
stop
assay
pcr
stop
assay
taq
dna
polymeras
stop
assay
pcr
stop
assay
gregion
overlap
primer
util
pcr
amplif
absenc
doublestrand
product
form
primer
anneal
extens
presenc
lead
stabil
templat
result
unavail
templat
primer
anneal
thu
pcr
got
inhibit
fulli
inhibit
higher
concentr
partial
inhibit
lower
concentr
shown
figur
increas
concentr
strong
impact
pcr
amplif
contrari
mutmtbpgq
use
dna
templat
inhibit
dna
synthesi
lead
full
product
gener
howev
taq
polymeras
stop
assay
assess
abil
stabil
structur
stop
movement
polymeras
enzym
pcr
extens
reaction
mtbpgq
site
figur
depict
result
taq
polymeras
stop
assay
three
templat
neg
control
absenc
fulllength
product
form
increas
concentr
shorter
band
observ
decreas
band
intens
wherea
neither
smaller
product
diminish
band
intens
observ
neg
control
reduc
transcript
espk
espb
gene
next
sought
examin
effect
transcript
motifpossess
gene
espk
espb
qrtpcr
transcript
gene
quantifi
rel
transcript
rrna
gene
housekeep
gene
quantif
cycl
cq
nontempl
control
cycl
shown
figur
treatment
tuberculosi
cell
mm
reduc
transcript
espk
espb
gene
respect
rel
untreat
cultur
control
result
strengthen
likelihood
role
mechan
transcript
motifcontain
gene
espk
espb
open
novel
therapeut
avenu
combat
deadli
human
pathogen
recent
recogn
highli
conserv
promis
drug
target
combat
infect
variou
polymorph
lethal
human
pathogen
exampl
presenc
motif
gene
promot
upregul
activ
hbv
insid
human
cell
recent
motif
gene
variou
structur
protein
zika
viru
found
promis
drug
target
similarli
case
kaposi
sarcomaassoci
herpesviru
kshv
motif
found
lie
kaposin
orilytr
orilytl
gene
observ
regul
replic
transcript
viral
genom
insid
host
cell
hiv
found
uniqu
long
termin
repeat
ltr
promot
region
propos
potent
target
antihiv
therapi
signal
requir
success
cleavag
packag
human
herpesviru
presenc
motif
region
suggest
novel
function
viral
genom
altogeth
bioinformat
analysi
h
nmr
cd
spectroscopi
emsa
reveal
presenc
conserv
intramolecular
parallel
motif
three
essenti
bacteri
gene
name
espk
espb
similar
target
abovement
human
pathogen
motif
present
gene
may
also
serv
potenti
target
develop
antibacteri
therapi
grich
target
also
overcom
problem
drug
resist
conserv
drugsuscept
drugresist
bacteri
strain
includ
extrem
drugresist
strain
present
code
region
espk
espb
gene
probe
presenc
gq
consequ
stabil
motif
use
wellknown
stabil
ligand
first
observ
increas
c
presenc
establish
presenc
pgq
sequenc
gene
second
presenc
pgq
sequenc
confirm
observ
stall
dna
replic
presenc
pcr
stop
assay
bind
interact
mtbpgq
determin
itc
analysi
thermodynam
stabl
energet
favor
select
final
evalu
inhibitori
effect
tuberculosi
growth
ic
valu
calcul
mm
highli
stabl
open
read
frame
gene
previous
shown
downregul
express
gene
treatment
tuberculosi
cultur
led
signific
decreas
express
espk
espb
rel
rrna
housekeep
gene
suggest
inhibit
mechan
involv
process
schemat
model
elabor
figur
inhibit
espk
espb
gene
expect
increas
innat
immun
respons
host
cell
inhibit
express
espb
espk
protein
would
restor
phagosom
matur
process
reduc
secret
turn
lead
rescu
antigen
present
host
immun
cell
conclus
current
studi
identifi
confirm
presenc
highli
conserv
motif
virul
determin
gene
tuberculosi
moreov
presenc
pgq
mycobacterium
speci
suggest
conserv
role
surviv
virul
bacteria
allow
us
propos
suitabl
therapeut
target
inhibit
bacteri
pathogen
presenc
gq
confirm
use
variou
biophys
approach
presenc
stabil
agent
lastli
inhibitori
role
gq
express
espk
espb
virul
gene
surviv
tuberculosi
demonstr
inhibit
intracellular
transcript
gene
take
togeth
result
studi
demonstr
espk
espb
gene
consid
novel
target
develop
antituberculosi
compound
pleas
see
supplement
inform
detail
explan
experiment
procedur
materi
use
studi
put
predict
tool
open
webbas
tool
predict
put
sequenc
differ
nucleotid
stretch
http
supplement
inform
found
onlin
http
author
declar
compet
interest
